Gene · 6392
Papers2,836
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 2,836
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Paired tumor sequencing and germline testing in breast cancer management: An experience of a single academic center. | Cancer Rep (Hoboken) | 2020 | 32881420 | PubTator, text mining | PubMed |
| Insights into the Role of microRNAs in Colorectal Cancer (CRC) Metabolism. | Cancers (Basel) | 2020 | 32878019 | PubTator, text mining | PubMed |
| Systemic vitamin intake impacting tissue proteomes. | Nutr Metab (Lond) | 2020 | 32863845 | PubTator, text mining | PubMed |
| Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma. | Curr Treat Options Oncol | 2020 | 32862332 | PubTator, text mining | PubMed |
| Usefulness of FDG-PET/CT-Based Radiomics for the Characterization and Genetic Orientation of Pheochromocytomas Before Surgery. | Cancers (Basel) | 2020 | 32859070 | PubTator, text mining | PubMed |
| Mefloquine Inhibits Esophageal Squamous Cell Carcinoma Tumor Growth by Inducing Mitochondrial Autophagy. | Front Oncol | 2020 | 32850358 | PubTator, text mining | PubMed |
| Cryo-EM structure of trimeric Mycobacterium smegmatis succinate dehydrogenase with a membrane-anchor SdhF. | Nat Commun | 2020 | 32843629 | PubTator, text mining | PubMed |
| Identification of MicroRNA-Related Tumorigenesis Variants and Genes in the Cancer Genome Atlas (TCGA) Data. | Genes (Basel) | 2020 | 32824926 | PubTator, text mining | PubMed |
| Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas. | Cancers (Basel) | 2020 | 32824391 | PubTator, text mining | PubMed |
| Case report expanding the germline AXIN2- related phenotype to include olfactory neuroblastoma and gastric adenoma. | BMC Med Genet | 2020 | 32807118 | PubTator, text mining | PubMed |
| Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer. | Cancers (Basel) | 2020 | 32806533 | PubTator, text mining | PubMed |
| Oncometabolites and the response to radiotherapy. | Radiat Oncol | 2020 | 32799884 | PubTator, text mining | PubMed |
| Novel ginsenoside derivative 20(S)-Rh2E2 suppresses tumor growth and metastasis in vivo and in vitro via intervention of cancer cell energy metabolism. | Cell Death Dis | 2020 | 32796841 | PubTator, text mining | PubMed |
| Phosphate Transporter Profiles in Murine and Human Thymi Identify Thymocytes at Distinct Stages of Differentiation. | Front Immunol | 2020 | 32793218 | PubTator, text mining | PubMed |
| 177Lu-DOTATATE therapy in metastatic/inoperable pheochromocytoma-paraganglioma. | Endocr Connect | 2020 | 32784267 | PubTator, text mining | PubMed |
| Prevalence of pathogenic variants in DNA damage response and repair genes in patients undergoing cancer risk assessment and reporting a personal history of early-onset renal cancer. | Sci Rep | 2020 | 32782288 | PubTator, text mining | PubMed |
| The roles of microRNA in redox metabolism and exercise-mediated adaptation. | J Sport Health Sci | 2020 | 32780693 | PubTator, text mining | PubMed |
| Clinical Outcome of Carotid Body Paraganglioma Management: A Review of 10-Year Experience. | J Oncol | 2020 | 32765605 | PubTator, text mining | PubMed |
| The Significance of Mitochondrial Dysfunction in Cancer. | Int J Mol Sci | 2020 | 32764295 | PubTator, text mining | PubMed |
| Hysteresis and bistability in the succinate-CoQ reductase activity and reactive oxygen species production in the mitochondrial respiratory complex II. | Redox Biol | 2020 | 32747163 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6392/papers?page=54